Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Sansen Pharmaceutical is a Chinese pharmaceutical company headquartered in Shijiazhuang, Hebei Province, specializing in the development, manufacturing, and distribution of chemical drugs and traditional Chinese medicines. Established in 2004, the company operates large-scale production facilities that are GMP-certified for various formulations, including tablets, capsules, and granules. Its core product portfolio is centered on respiratory health, particularly over-the-counter treatments for the common cold and influenza, as well as analgesics and anti-inflammatory medications. Hebei Sansen maintains a significant market presence in China through its Sansen brand, focusing on high-quality, accessible generic pharmaceuticals. The company continues to expand its manufacturing capabilities to support both domestic demand and potential international collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 河北三森药业.